THE BIOAVAILABILITY AND PHARMACOKINETICS OF GUANFACINE AFTER ORAL AND INTRAVENOUS ADMINISTRATION TO HEALTHY-VOLUNTEERS

被引:17
作者
CARCHMAN, SH [1 ]
CROWE, JT [1 ]
WRIGHT, GJ [1 ]
机构
[1] AH ROBINS CO INC,DEPT SCI INFORMAT,RICHMOND,VA 23220
关键词
D O I
10.1002/j.1552-4604.1987.tb02993.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:762 / 767
页数:6
相关论文
共 8 条
[1]  
BEVERIDGE T, 1977, GUANFACINE ADME STUD
[2]   PHARMACOKINETICS AND METABOLISM OF GUANFACINE IN MAN - A REVIEW [J].
KIECHEL, JR .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1980, 10 :S25-S32
[3]   ELIMINATION OF GUANFACINE IN PATIENTS WITH NORMAL AND IMPAIRED RENAL-FUNCTION [J].
KIRCH, W ;
KOHLER, H ;
BRAUN, W .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1980, 10 :S33-S35
[4]   THE INFLUENCE OF RENAL-FUNCTION ON PLASMA-CONCENTRATION, URINARY-EXCRETION AND ANTIHYPERTENSIVE EFFECT OF GUANFACINE [J].
KIRCH, W ;
KOHLER, H ;
BRAUN, W ;
GIZYCKI, CV .
CLINICAL PHARMACOKINETICS, 1980, 5 (05) :476-483
[5]  
ROSENBAUM MS, 1983, PEDIATRICS, V71, P359
[6]   PHARMACOLOGY OF GUANFACINE [J].
SCHOLTYSIK, G .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1980, 10 :S21-S24
[7]  
WEISS YA, 1979, CLIN PHARMACOL THER, V25, P283
[8]  
1982, SAS USERS GUIDE BASI